300981.SHE Zhonghong Pulin Medical Products Co. Ltd.
- Market cap
- CNY 6.41B
- P/E
- 42.7x
- P/B
- 1.20x
- ROE
- 6.3%
- Dividend yield
- 1.97%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300981.SHE undervalued?
Graham number300981.SHE trades 50.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhonghong Pulin Medical Products Co. Ltd. fundamental analysis
No fundamental analysis for Zhonghong Pulin Medical Products Co. Ltd. yet.
Zhonghong Pulin Medical Products Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division segments. The Health Protection Products Division is involved in the research, …
Full company profileZhonghong Pulin Medical Products Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhonghong Pulin Medical Products Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 710M | 951M | 968M | 1.17B | 4.78B | 4.91B | 1.57B | 2.11B | 2.46B | 2.37B | 2.99B |
| Gross Profit | 124M | 180M | 166M | 219M | 3.38B | 2.88B | 18.9M | 98.3M | 274M | 265M | 741M |
| Operating Income | 48.3M | 86.3M | 70.4M | 106M | 3.19B | 2.79B | -11.0M | -137M | -65.7M | -53.3M | 454M |
| EBITDA | 93.3M | 130M | 121M | 173M | 3.27B | 2.86B | 197M | 77.5M | 171M | 130M | 414M |
| Net Income | 38.2M | 65.0M | 56.7M | 89.3M | 2.66B | 2.34B | 66.9M | -131M | -87.1M | -112M | 338M |
| EPS | 0.15 | 0.20 | 0.17 | 0.28 | 8.28 | 5.96 | 0.15 | -0.31 | -0.20 | -0.26 | 0.79 |
| Balance Sheet | |||||||||||
| Total Assets | 629M | 698M | 975M | 1.08B | 3.67B | 7.15B | 6.82B | 7.06B | 7.23B | 7.44B | 7.80B |
| Total Liabilities | 374M | 378M | 599M | 608M | 1.12B | 598M | 684M | 1.14B | 1.61B | 2.02B | 2.30B |
| Shareholders' Equity | 257M | 321M | 378M | 468M | 2.56B | 6.55B | 6.12B | 5.77B | 5.47B | 5.26B | 5.35B |
| Cash & Short-term Investments | 66.4M | 66.1M | 31.7M | 71.0M | 1.56B | 4.41B | 3.03B | 2.93B | 2.33B | 1.21B | 742M |
| Total Debt | 174M | 170M | 302M | 330M | 107M | 17.2M | 67.1M | 492M | 730M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 102M | 96.0M | 23.8M | 184M | 2.72B | 2.36B | 107M | 141M | 184M | 3.74M | - |
| Capital Expenditure | 61.7M | 78.1M | 203M | 150M | 429M | 961M | 208M | 103M | 107M | 191M | 45.0M |
| Free Cash Flow | 40.7M | 17.9M | -179M | 33.9M | 2.29B | 1.40B | -101M | -61.4M | 76.5M | -187M | 531M |
| Ratios | |||||||||||
| ROE | 14.9% | 20.2% | 15.0% | 19.1% | 104.2% | 35.7% | 1.1% | -2.3% | -1.6% | -2.1% | 6.3% |
| ROA | 6.1% | 9.3% | 5.8% | 8.3% | 72.5% | 32.7% | 1.0% | -1.9% | -1.2% | -1.5% | 4.3% |
| Net Profit Margin | 5.4% | 6.8% | 5.9% | 7.6% | 55.7% | 47.7% | 4.3% | -6.2% | -3.5% | -4.7% | 11.3% |
| Debt to Equity | 0.68x | 0.53x | 0.80x | 0.70x | 0.04x | 0.00x | 0.01x | 0.09x | 0.13x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhonghong Pulin Medical Products Co. Ltd. dividends
- Dividend yield
- 1.97%
- Forward dividend
- 0.35 CNY
- Payout ratio
- -
- Ex-dividend date
- May 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 127M | 0.29 | - |
| 2024 | CNY 216M | 0.50 | - |
| 2023 | CNY 295M | 0.70 | - |
| 2022 | CNY 500M | 1.15 | 747.2% |
| 2021 | CNY 250M | 0.64 | 10.7% |
| 2020 | CNY 575M | 1.79 | 21.6% |
| 2019 | CNY 19.8M | 0.06 | 22.1% |
| 2018 | 14.0M | 0.04 | 24.7% |
| 2017 | 8.56M | 0.03 | 13.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.1:1 on Jun 27, 2025.
Who owns Zhonghong Pulin Medical Products Co. Ltd.
- Insiders 73.15%
- Institutions 0.46%
- Public & others 26.39%
- Shares outstanding 429M
- Free float 117M
Zhonghong Pulin Medical Products Co. Ltd. company profile
- Company name
- Zhonghong Pulin Medical Products Co. Ltd.
- Ticker
- 300981.SHE
- ISIN
- CNE100004KR0
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 3,884
- Fiscal year end
- December
- Address
- Chengxi Park, Tangshan, China, 063500
- Phone
- 86 31 5415 5760
- Website
- zhonghongmedical.com
About Zhonghong Pulin Medical Products Co. Ltd.
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division segments. The Health Protection Products Division is involved in the research, development, production, and sale of nitrile gloves, PVC gloves, natural latex gloves, radiation protection gloves, polyisoprene gloves, and other gloves and condoms. The Safe Infusion Products Division engages in the research, development, production, and sale of infusion device-related products, such as precision infusion sets, indwelling needles, ordinary infusion sets, ordinary syringes, and blood collection tubes. The Innovation and Incubation Product Division is involved in the research, development, production, and sale of products and equipment, including infusion pumps, syringe pumps, infusion information acquisition systems, disposable non-invasive EEG electrodes, disposable medical temperature sensors, non-invasive blood pressure cuffs, and radial artery compression tourniquets. The company also provides wireless continuous monitoring sensors and probes; and scientific research and technical services. Zhonghong Pulin Medical Products Co., Ltd. was founded in 2010 and is based in Tangshan, China.
Zhonghong Pulin Medical Products Co. Ltd. management
5- Ms. Hao YangGeneral Manager · born 1988
- Mr. Wen Long WangDeputy GM & Financial Director · born 1988
- Mr. Mingang LiDeputy General Manager · born 1971
- Yuzhu ZhangAccounting Supervisor
- Mr. Wei DengBoard Secretary · born 1989